Pages that link to "Q40702136"
Jump to navigation
Jump to search
The following pages link to Célia Duarte Cruz (Q40702136):
Displayed 38 items.
- Vanilloid receptor 1 expression in the rat urinary tract (Q30829557) (← links)
- Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study (Q33800907) (← links)
- The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). (Q35044823) (← links)
- Neurotrophins in the lower urinary tract: becoming of age (Q35687029) (← links)
- The ERK 1 and 2 pathway in the nervous system: from basic aspects to possible clinical applications in pain and visceral dysfunction (Q37420455) (← links)
- Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target (Q37869049) (← links)
- Neurotrophins as regulators of urinary bladder function (Q38050405) (← links)
- Neurotrophins in bladder function: what do we know and where do we go from here? (Q38115263) (← links)
- Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview (Q38212859) (← links)
- Biomarkers of spinal cord injury and ensuing bladder dysfunction (Q38274945) (← links)
- Urinary neurotrophic factors in healthy individuals and patients with overactive bladder (Q39240698) (← links)
- Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist (Q39692342) (← links)
- An update on neurotrophins (Q40576492) (← links)
- Nerve growth factor regulates galanin and c-jun overexpression occurring in dorsal root ganglion cells after intravesical resiniferatoxin application (Q40702032) (← links)
- Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis (Q42205403) (← links)
- Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats (Q42493866) (← links)
- Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder (Q43203907) (← links)
- ACTH modulates ERK phosphorylation in the adrenal gland in a time-dependent manner (Q45235668) (← links)
- Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation (Q45283864) (← links)
- GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models (Q46245642) (← links)
- Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals (Q46340915) (← links)
- Effect of onabotulinumtoxinA on intramural parasympathetic ganglia: an experimental study in the guinea pig bladder (Q46657620) (← links)
- Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis (Q48273100) (← links)
- Urinary Neurotrophin Levels Increase in Women With Stress Urinary Incontinence After a Midurethral Sling Procedure (Q48489285) (← links)
- Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis (Q48611597) (← links)
- Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A. (Q53090822) (← links)
- Spinal cord injury and bladder dysfunction: new ideas about an old problem. (Q55335493) (← links)
- Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action (Q57098212) (← links)
- Reply from Authors re: Prokar Dasgupta. Volume Matters: Bladder Injections of Botulinum Toxin Type A. Eur Urol 2012;61:1185–6 (Q59282549) (← links)
- 817 URINARY NEUROTROPHIC FACTORS IN BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS (Q59282558) (← links)
- Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input (Q59282561) (← links)
- Animal Models of Cystitis (Q59282588) (← links)
- 813 INCREASED SYMPATHETIC ACTIVITY ENHANCES BLADDER HYPERACTIVITY AND TRIGGERS BLADDER PAIN (Q59282628) (← links)
- 1677 INTRA-TRIGONAL INJECTION OF BOTULINUM TOXIN A IN PATIENTS WITH REFRACTORY BLADDER PAIN SYNDROME DECREASES URINARY NEUROTROPHINS AND IMPROVES LOWER URINARY TRACT SYMPTOMS (Q59282661) (← links)
- 191 EFFECT OF BOTULINUM TOXIN TYPE A ON INTRAMURAL PARASYMPATHETIC GANGLIA OF THE GUINEA-PIG BLADDER (Q59282662) (← links)
- HIGH AFFINITY BINDING SITES FOR BOTULINUM TOXIN TYPE A IN THE URINARY BLADDER: DISTRIBUTION AND NEUROCHEMISTRY (Q59282673) (← links)
- THE ORAL TRPV1 ANTAGONIST GRC 6211 REDUCES BLADDER OVERACTIVITY AND NOXIOUS BLADDER INPUT IN CYSTITIS (Q59282675) (← links)
- Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity (Q92628876) (← links)